Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2004The Journal of Urology

EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER

View Full Paper
Ask AI
Bookmark
Share

Authors

GAGerald L. AndrioleUniversity of North Carolina at Chapel HillPHPeter A. HumphreyUniversity of Maryland, BaltimorePRP. RAY

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Andriole et al. (2004) studied this question.

synapsesocial.com/papers/6a8afca22ff0ab4f91e94bcchttps://doi.org/10.1097/01.ju.0000136430.37245.b9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications1986 · 60 citations
  2. 2Kinetic Parameters of 5α-Reductase Activity in Stroma and Epithelium of Normal, Hyperplastic, and Carcinomatous Human Prostates*1988 · 102 citations
  3. 3Response of rat and human prostatic cancers to the novel 5α‐reductase inhibitor, SK&F 1056571992 · 61 citations
  4. 45α-Reductase Type 1 Immunostaining is Enhanced in Some Prostate Cancers Compared With Benign Prostatic Hyperplasia Epithelium2003 · 80 citations